US2007218532A1PendingUtilityA1
Novel Escherichia coli having accession no. PTA 1579 and its use to produce polyhydroxybutyrate
Individually held — no corporate assignee on recordPriority: Jan 29, 2001Filed: Sep 11, 2006Published: Sep 20, 2007
Est. expiryJan 29, 2021(expired)· nominal 20-yr term from priority
C12N 15/70Y02P20/582C12P 7/625C12N 15/52
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a novel genetically modified Escherichia coil JM109 bearing accession number PTA 1579, containing the gene coding for poly-beta-hydroxybutyrate synthesis and a method of using this bacterium to produce poly-beta-hydroxybutyrate to the extent of 60% or more of the cell weight.
Claims
exact text as granted — not AI-modified1 - 5 . (canceled)
6 . A method for producing poly-beta-hydroxybutyrate, said method comprising:
(i) isolating a nucleic acid encoding the proteins responsible for poly-beta-hydroxybutyrate synthesis from Streptomyces aureofaciens NRRL2209, (ii) cloning said nucleic acid into a plasmid vector to obtain a recombinant vector, (iii) transforming Escherichia coli with said recombinant vector to obtain recombinant Escherichia coli which expresses said proteins responsible for poly-beta-hydroxybutyrate synthesis, and (iv) culturing said recombinant Escherichia coli in a conventional medium comprising glycerol and one or more substrates, and (v) recovering said poly-beta-hydroxybutyrate.
7 . The method according to claim 6 wherein the nucleic acid encoding the proteins responsible for poly-beta-hydroxybutyrate synthesis is a 4.826 Kb fragment.
8 . (canceled)
9 . A method as claimed in The method according to claim 6 wherein the plasmid vector is a multicopy plasmid vector.
10 . The method according to claim 6 wherein the recombinant plasmid vector is pSa240.
11 . The method according to claim 10 wherein the Escherichia coli is transformed at a temperature in the range of 14°-18° C. in the presence of T4 DNA ligase enzyme.
12 . (canceled)
13 . The method according to claim 6 wherein the hydroxybutyrate is produced in recoverable quantities of at least about 60% (w/w) of the recombinant E. coli dry cell mass.
14 . The method according to claim 6 , wherein the nucleic acid comprises the sequence of SEQ ID NO. 1.
15 . The method according to claim 9 , wherein the multicopy plasmid vector is pGEM-3Z.Join the waitlist — get patent alerts
Track US2007218532A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.